Marketing Business Weekly
Welcome to VerticalNews!
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Guided Therapeutics Completes $3 Million Financing
October 3rd, 2010
Guided Therapeutics, Inc. (GT) (OTCBB: GTHP) announced that it has completed a private financing of approximately $3 million. Terms of the financing include 3,771,605 million common shares priced at $0.81 per share. For each share of common stock issued, warrants exercisable for the purchase of one-tenth (1/10th) of one share of common stock at an exercise price equal to $1.01 per share were issued. The warrants will have an exercise period of five years from date of issuance. About Guided Therapeutics Guided Therapeutics, Inc. (OTCBB: GTHP) is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed...
Click here for more articles from Cervical Cancer
Source: Marketing Business Weekly (2010-10-03)
|
